Scott Wagner Buys Shares in GoodRx Holdings, Inc.
Scott Wagner acquired 73,434 shares of GoodRx Holdings, Inc. on June 16, 2026.
Key Points
- Scott Wagner purchased 73,434 shares of GoodRx Holdings, Inc. on June 16, 2026.
- GoodRx, trading at $2.73, has a market cap of about $924.6 million and a P/E ratio of 45.5.
- Analysts maintain a 'hold' consensus with a mean target price of $3.18.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Scott Wagner bought 73,434 shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) on June 16, 2026. This insider transaction occurred as the stock traded around $2.73 per share.
Insider Buying and Selling at GoodRx Holdings, Inc.
Several insiders, including Scott Wagner, made identical purchases of 73,434 shares each on June 16, 2026. These purchases were not part of a pre-arranged trading plan.
Other Institutional Activity in GoodRx Holdings
Francisco Partners Management, LP maintains its significant stake in GoodRx with 60,078,184 shares valued at approximately $117.8 million. LSV Asset Management increased its holdings by 2,156,031 shares, bringing its total to 4,981,931 shares worth about $9.8 million. Ameriprise Financial Inc added 1,183,329 shares, ending with 4,455,760 shares valued at $8.7 million. Vanguard Capital Management LLC and Vanguard Portfolio Management LLC both initiated new positions, each holding 4,261,516 and 3,362,864 shares respectively.
GoodRx Holdings, Inc. Stock Down 26.1%
Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) are trading near $2.73. The company has a market capitalization of approximately $924.6 million and a P/E ratio of 45.5. Its forward P/E is 7.6, indicating expectations of higher future earnings. The beta of 1.615 suggests that the stock is more volatile than the market. The stock's 52-week range is between $1.77 and $5.81, with a 50-day moving average of $2.54 and a 200-day moving average of $2.89.
Recent Earnings
GoodRx reported revenue of $787.9 million, with a slight decline in revenue growth of 4.4%. The company achieved a net margin of 2.6% and a return on equity of 3.2%. The next earnings report is scheduled for August 5, 2026.
Analysts Set New Price Targets
On May 14, 2026, Citigroup maintained its 'buy' rating for GoodRx with a price target of $4. TD Cowen also maintained a 'buy' rating with the same target on May 11, 2026. The consensus among 13 analysts is a 'hold' rating, with an average target price of $3.18.
About GoodRx Holdings, Inc.
GoodRx Holdings, Inc. provides a platform for consumers to compare prescription drug prices and save money in the United States. Based in Santa Monica, California, the company also offers subscription programs and telehealth services through GoodRx Care. Founded in 2011, GoodRx serves pharmacy benefit managers and provides healthcare solutions for both humans and pets. The company is led by CEO Wendy Barnes and employs about 697 people.
Bottom Line
Scott Wagner's purchase of GoodRx shares is a notable move among several insiders. GoodRx's stock performance and institutional interest are closely watched by investors, given its volatile market behavior and strategic position in the healthcare sector. As always, remember that insider purchases can be for various reasons and do not necessarily predict future stock performance.
Get GoodRx Holdings, Inc. alerts
New 13F filings, insider trades, and analyst moves on $GDRX, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.